Company intelligence / Profile preview

安徽雷允上药业

Ownership: Private
Employees: ~240
Development stage: Commercial

Overview

安徽雷允上药业 specializes in modern TCM formulations with several products included in the National Reimbursement Drug List. The company has received clinical trial approvals for new indications such as COVID-related therapies and chronic conditions like COPD and hyperphosphatemia. Its main products have strong potential in cerebrovascular disease treatment. In 2021, sales revenue reached 550 million RMB (~$85M USD), with a target of 1.5 billion RMB by 2025.

Therapeutic areas: PulmonologyOncologyOtherNeurologyGastroenterologyCardiovascularNephrologyWomen's Health
Modalities: Small moleculeHerbal medicineTraditional Chinese medicine
Industry: Biotech

Drug pipeline

3 assets

naoan capsule

Commercial

Indications: Cerebral thrombosis, Vascular dementia

2 more assets in the full pipeline.

Request access →

Partnerships

China Pharmaceutical UniversityShenyang Pharmaceutical UniversityInstitute of Materia Medica at Chinese Academy of Medical Sciences

Beyond the preview

Go deeper on 安徽雷允上药业.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 安徽雷允上药业.

Explore the full profile